Undertaking this mammoth project at the 113ha site in Malacca is California-based Actis Biologics Inc, a bio-pharmaceutical company which has set up a Malaysian-registered company Actis Biologics Malaysia Sdn Bhd.
Actis co-founder and chairman Sanjeev Saxena said the making of the Bio-City in Malaysia was with the vision to create a competitive, self sufficient Life Sciences industry, create global recognition and ensure investors had good returns.
"Malaysia will also become the hub for the commercialisation of existing research. The biotech hub will also create jobs for thousands of people."
Saxena said his company intends to create Life Science and Life Science-related companies focusing on cardiovascular diseases, anti-cancer, diabetes, respiratory disorders, neurological disorders, regenerative medicines and ophthalmological indications.
Actis Biologics president P.N. Venugopalan said the company would develop therapeutic treatments and would continue its research into vaccines and medications for each of the segments.
Telesto Diagnostics is a medical device company set up by Actis Biologics Malaysia to focus on medical computer-aided diagnosis for breast cancer software.
click here for full story
0 Comments:
Post a Comment